论文部分内容阅读
一种防治运动病新药——膜控释型东莨菪贴片,最近在空军南京医院研制成功,并通过技术鉴定,由安徽蚌埠涂山药厂生产。东莨菪碱作为抗M-胆碱能受体药物早已用于临床。该药具有解除平滑肌痉挛、改善微循环、抑制腺体分泌、解除迷走神经对心脏的抑制、散大瞳孔、兴奋呼吸中枢等作用,临床应用甚广,抗运动病为其主要用途之一。经研究,其抗运动病作用可能和抑制前庭神经、大脑皮层和胃肠运动有关,属抗运动病疗效较好的药物之一,但常规剂型存在的
A new drug for the prevention and treatment of motion sickness - the film-controlled release of scopolamine patch, recently developed in the Air Force Nanjing Hospital, and passed the technical appraisal, from Anhui Bengbu Tuyen pharmaceutical production. Scopolamine has long been used clinically as an anti-M-cholinergic receptor drug. The drug has relieve smooth muscle spasm, improve microcirculation, inhibit glandular secretion, relieve vagal nerve inhibition of the heart, dilated pupils, excite the respiratory center role, the clinical application is very wide, anti-motion sickness is one of its main purposes. The study, its anti-motion sickness may inhibit the vestibular nerve, cerebral cortex and gastrointestinal motility, anti-motion sickness is one of the better drug efficacy, but the conventional formulations exist